We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Hillman Solutions
HLMN
$1.72B
| $593K | ﹤0.01% |
56,200
+10,300
| +22% | +$99.4K |
|
|
AY
1177
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $593K | ﹤0.01% |
26,991
+5,200
| +24% | +$115K |
|
|
LTC
1178
LTC Properties
LTC
$2.1B
| $592K | ﹤0.01% |
16,130
+6,700
| +71% | +$243K |
|
1179
TAL Education Group
TAL
$6.36B
| $592K | ﹤0.01% |
50,000
| – | – |
|
|
TGNA
1180
DELISTED
TEGNA Inc
TGNA
| $592K | ﹤0.01% |
37,508
| – | – |
|
1181
Evolent Health
EVH
$499M
| $591K | ﹤0.01% |
20,900
| – | – |
|
1182
Edgewell Personal Care
EPC
$1.32B
| $589K | ﹤0.01% |
16,202
+6,800
| +72% | +$262K |
|
1183
CorVel
CRVL
$3.21B
| $588K | ﹤0.01% |
5,400
+600
| +13% | +$60K |
|
1184
Wendy's
WEN
$1.64B
| $586K | ﹤0.01% |
33,457
| – | – |
|
1185
Surgery Partners
SGRY
$1.98B
| $584K | ﹤0.01% |
18,100
+4,700
| +35% | +$139K |
|
|
OPLN
1186
Openlane
OPLN
$4.36B
| $583K | ﹤0.01% |
34,525
| – | – |
|
1187
Associated Banc-Corp
ASB
$6.07B
| $581K | ﹤0.01% |
26,962
| – | – |
|
1188
Cohen & Steers
CNS
$4.37B
| $581K | ﹤0.01% |
6,051
+800
| +15% | +$68K |
|
1189
Fulton Financial
FULT
$4.69B
| $580K | ﹤0.01% |
32,013
| – | – |
|
1190
Acushnet Holdings
GOLF
$5.28B
| $580K | ﹤0.01% |
9,100
+1,600
| +21% | +$106K |
|
1191
First Interstate BancSystem
FIBK
$3.69B
| $575K | ﹤0.01% |
18,753
| – | – |
|
|
AKRO
1192
DELISTED
Akero Therapeutics
AKRO
| $574K | ﹤0.01% |
20,000
+2,200
| +12% | +$57.4K |
|
1193
Agilysys
AGYS
$3.09B
| $573K | ﹤0.01% |
5,259
+900
| +21% | +$96.3K |
|
1194
Atlanta Braves Holdings Series B
BATRK
$3.42B
| $572K | ﹤0.01% |
14,377
+2,500
| +21% | +$105K |
|
1195
Levi Strauss
LEVI
$8.62B
| $571K | ﹤0.01% |
26,200
| – | – |
|
1196
AC Immune
ACIU
$265M
| $567K | ﹤0.01% |
150,000
| – | – |
|
1197
Minerals Technologies
MTX
$2.27B
| $567K | ﹤0.01% |
7,337
+700
| +11% | +$53.9K |
|
1198
Keros Therapeutics
KROS
$216M
| $563K | ﹤0.01% |
9,700
+1,700
| +21% | +$84K |
|
|
INFN
1199
DELISTED
Infinera Corporation Common Stock
INFN
| $563K | ﹤0.01% |
83,406
+25,600
| +44% | +$158K |
|
1200
RingCentral
RNG
$5.49B
| $562K | ﹤0.01% |
17,770
| – | – |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.